
European Markets Move Higher as Growth Fears Remain
By Scott Kanowsky Investing.com -- European markets moved higher on Friday, adding to momentum from a late rally on Wall Street, but sentiment remains cautious as recent economic data...
By Scott Kanowsky Investing.com -- European markets moved higher on Friday, adding to momentum from a late rally on Wall Street, but sentiment remains cautious as recent economic data...
By Peter Nurse Investing.com - European stock markets are expected to open higher Friday, boosted by the previous session’s late rally on Wall Street, but sentiment remains fragile as...
PARIS (Reuters) – Sanofi’s COVID-19 vaccine candidate, which is modelled on the virus’s Beta antigen, delivered 72% efficacy in adults against the Omicron strain, the French drugmaker...
This initial collaboration resulted in promising molecules for an oncology program, for which Sanofi and Aqemia decided to pursue joint efforts, the company claims.
A COVID-19 vaccine developed by Sanofi SA and GSK PLC to target the Beta strain of the virus produced a stronger antibody response against variants of omicron when given as a booster...
Results from two new studies are the latest indication that tweaking vaccines can nudge antibody responses in the direction of new variants, possibly helping to shore up immunity as the...
The companies point to the risk of new variants and waning immunity that could lead to an increase in demand for additional booster shots in some populations.
Sanofi said Monday that preliminary data shows that its experimental next-generation COVID-19 booster provided a 40-fold increase in antibody protection against BA.1, a subvariant of...
By Peter Nurse Investing.com - European stock markets traded lower Monday, with weak UK growth data raising fears of an economic slowdown in the region just as central banks move to address...
By Peter Nurse Investing.com - European stock markets are expected to open sharply lower Monday, continuing the global selloff after red-hot inflation data raised fears of aggressive Federal...
PARIS (Reuters) – French drugmaker Sanofi on Monday said the COVID-19 vaccine candidate it has developed jointly with GSK in two trials showed a potential to protect against the virus’s...
The U.S. Food and Drug Administration (FDA) has approved Regeneron Pharmaceuticals (NASDAQ: REGN) and Sanofi’s (NASDAQ: SNY) lead drug candidate Dupixent (dupilumab) for children aged 6...
(Reuters) – The U.S. Food and Drug Administration approved the use of Sanofi and Regeneron Pharmaceuticals Inc’s anti-inflammation drug Dupixent to treat eczema in young children, the...
(Reuters) -Regeneron Pharmaceuticals said on Thursday it would buy the global rights to cancer drug Libtayo from French drugmaker Sanofi SA in a deal that includes an upfront payment of $900...
Regeneron Pharmaceuticals Inc. announced Thursday an agreement in which it will pay up to $1.1 billion plus royalties for Sanofi S.A.'s stake in the Regeneron-Sanofi collaboration on...
Futnani has over two decades of experience in growth and transformation that spans several therapeutic areas and functions within healthcare and finance.
Sanofi said Wednesday that the Food and Drug Administration granted a Breakthrough Therapy designation to the hemophilia A treatment it's developing with Swedish Orphan Biovitrum AB . The...
Futnani has over two decades of experience in delivering growth and transformation that spans several therapeutic areas and functions within healthcare (primary and specialty care, medical...
By Peter Nurse Investing.com -- Stocks in focus in premarket trade on Tuesday, May 31st. Please refresh for updates. Zoom (NASDAQ:ZM) stock rose 1.6% after Daiwa upgraded its stance on the...
The U.S. Food and Drug Administration (FDA) has accepted a supplemental Biologics License Application (sBLA) for review submitted by Regeneron Pharmaceuticals (NASDAQ: REGN) and Sanofi...
While Sanofi, like many other multinationals, settled this with the taxman under India's plan to rescind the indirect transfer of assets amendment or retrospective tax amendment in December,...
Co-developed by Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi (NASDAQ: SNY), Dupixent has bagged the U.S. Food and Drug Administration’s approval to treat eosinophilic...
The U.S. Food and Drug Administration (FDA) has approved Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi’s (NASDAQ: SNY) lead drug candidate Dupixent® (dupilumab) 300 mg weekly for...
A French court has ordered Sanofi SA (NASDAQ: SNY) to pay more than €400,000 in damages to a French family whose child had autism caused by its epilepsy drug Valproate. The court mentioned...
Sanofi SA (NASDAQ: SNY) shared the latest results from the Phase 3 IKEMA trial evaluating Sarclisa (isatuximab) in patients with relapsed multiple myeloma receiving a proteasome inhibitor...
PARIS (Reuters) – A French court has ordered Sanofi to pay more than 400,000 euros ($416,440) in damages to a family whose child suffered from a form of autism caused by its epilepsy...
Arkansas has accused Eli Lilly And Co (NYSE: LLY), Novo Nordisk A/S (NYSE: NVO), Sanofi SA (NASDAQ: SNY), and three of the largest pharmacy benefit managers (PBMs) of artificially driving up...
DarioHealth Corp. (Nasdaq: NASDAQ:DRIO), a leader in the global digital therapeutics (DTx) market, today reported financial results for the first quarter 2022 and provided a corporate and...
It's carnage across the markets with stocks falling across the board. The Sensex has fallen for the 5th straight day. Here are some stocks that have been beaten down.
Teladoc (NYSE: TDOC) stock recently cratered to a new 52 week low following it’s Q1 report. Some of it’s shortfall was attributed by management to longer sales cycles in the insurer and...
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Veru Suggested By FDA To Submit Emergency Use Request For Sabizabulin In COVID-19 In a...
Sanofi SA (NASDAQ: SNY) and AstraZeneca plc (NASDAQ: AZN) have announced results from a prespecified pooled analysis of nirsevimab in respiratory syncytial virus (RSV). Results from the...
MOUNTAIN VIEW, Calif., May 06, 2022 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (NASDAQ:IGMS), a clinical-stage biotechnology company focused on creating and developing engineered IgM...
PARIS (Reuters) – Shares in EUROAPI, the drug ingredients business being spun-off by Sanofi, rose on Friday as the company made its debut on the Paris stock market.
Products in the price control list and growth of the non-power brand portfolio will be key monitorables
Partner Sanofi has commenced dosing in a Phase 2 clinical trial of SAR443820 (DNL788) in individuals with amyotrophic lateral sclerosis (ALS) Denali to receive a milestone payment of $40...
Sanofi reported strong results for Q1CY22 with operating margins expanding 139 bps y-o-y and were better than estimated, leading to a PAT ahead of estimates.
Investing.com - Sanofi (EPA:SASY) ADR reported on Thursday first quarter {{erl-21258||earnings that beat analysts' forecasts and revenue that topped expectations. Sanofi ADR announced...
Investing.com - Sanofi (EPA:SASY) reported on Thursday first quarter {{erl-414||earnings that beat analysts' forecasts and revenue that topped expectations. Sanofi announced earnings per...
By Peter Nurse Investing.com - European stock markets are expected to open higher Thursday as investors await the latest moves in the spat with Russia over gas supplies to Europe while...
By Peter Nurse Investing.com - European stock markets traded in a mixed fashion Friday, with investors cautiously monitoring fresh negotiations aimed at ending the war in Ukraine, the spat...
By Peter Nurse Investing.com - European stock markets are expected to open largely unchanged Thursday at the end of a turbulent month, with investors carefully watching developments in the...
By Sam Boughedda Investing.com -- IGM Biosciences Inc (NASDAQ:IGMS) announced a collaboration agreement with Sanofi (PA:SASY) (NASDAQ:SNY) on Tuesday, causing its shares to...
By Sam Boughedda Investing.com -- U.S. indices are gaining Tuesday on hopes that talks between Ukraine and Russia will result in a ceasefire. Here are the midday movers on Tuesday, March...
By Peter Nurse Investing.com - European stock markets traded higher Tuesday with the focus on the start of another round of peace talks between Ukraine and Russia in Turkey. By 4:10 AM ET...
By Peter Nurse Investing.com - European stock markets are expected to open marginally higher Tuesday ahead of the start of another round of peace talks between Ukraine and Russia in Turkey...
By Dhirendra Tripathi Investing.com – Sanofi (PA:SASY) (NASDAQ:SNY) ADRs traded 2.5% lower in premarket Monday after an experimental cancer medicine failed to slow progression of a...
Investing.com - Sanofi (PA:SASY) reported on Friday fourth quarter {{erl-414||earnings that beat analysts' forecasts and revenue that topped expectations. Sanofi announced earnings per...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.